12.3.2026
The National AIDS, Viral Hepatitis and STIs Control Programme (NASCP) said Nigeria has received the HIV prevention drug Lenacapavir.
NASCP working under the Federal Ministry of Health and Social Welfare disclosed that the first shipment of the injectable drug arrived in the country on Tuesday. According to the agency, Lenacapavir will be used for pre-exposure prophylaxis (PrEP), a preventive treatment for people at risk of HIV infection.
The agency said in a statement that the milestone, approved by the coordinating minister of health and social welfare, Muhammad Pate and supported by the Global Fund, represents a significant advancement in Nigeria’s HIV prevention efforts..
“The introduction of Lenacapavir for PrEP marks a significant step towards broadening the range of prevention choices available to individuals at risk of HIV infection,” the statement noted.
“As a long-acting injectable option, LEN PrEP has the potential to improve adherence and expand access to effective HIV prevention services for populations that may face challenges with daily oral prevention options.”
Lenacapavir is a long-acting injectable medication used for HIV prevention through PrEP, a treatment taken by people who are HIV-negative but at risk of infection.